Search

Search Results
Results 4421 - 4430 of 4467 for multiple sclerosis
  • Remicade
    Drug - 16 Dec 2022
    Consumer Medicine Information (CMI) about Remicade (Infliximab) intended for persons living in Australia.
  • Using Chinese hamster ovary cells as a bioprocessing tool
    White Paper - 16 Nov 2022
    This article describes the importance of Chinese Hamster Ovary cells (CHO cells) for scientific discovery and bioprocessing.
  • Diabex XR 500 and 1000
    Drug - 17 Oct 2022
    Consumer Medicine Information (CMI) about Diabex XR 500 and 1000 intended for persons living in Australia.
  • Diabex
    Drug - 14 Oct 2022
    Consumer Medicine Information (CMI) about Diabex intended for persons living in Australia.
  • Jardiamet
    Drug - 21 Sep 2022
    Consumer Medicine Information (CMI) about Jardiamet (empagliflozin / metformin hydrochloride) intended for persons living in Australia.
  • Amgevita
    Drug - 7 Sep 2022
    Consumer Medicine Information (CMI) about Amgevita intended for persons living in Australia.
  • Actemra
    Drug - 5 Sep 2022
    Consumer Medicine Information (CMI) about Actemra intended for persons living in Australia.
  • Natrilix SR
    Drug - 26 Jul 2022
    Consumer Medicine Information (CMI) about Natrilix SR (Sustained Release tablets containing indapamide) intended for persons living in Australia.
  • Natrilix
    Drug - 26 Jul 2022
    Consumer Medicine Information (CMI) about Natrilix (indapamide) intended for persons living in Australia.
  • Odaplix SR
    Drug - 26 Jul 2022
    Consumer Medicine Information (CMI) about Odaplix SR (Sustained Release tablets containing indapamide) intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback